A tuber-ful animal model of tuberous sclerosis at last?

Epilepsy Currents

Volumn 12, Issue 1, 2012, Pages 15-16

  Wong, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN TSC1; TUBERIN; UNCLASSIFIED DRUG;

ALLELE; ASTROCYTE; BRAIN DAMAGE; BRAIN DEVELOPMENT; CELL TYPE; DISEASE MODEL; ELECTROENCEPHALOGRAM; ELECTROPORATION; EPILEPTOGENESIS; GENE INACTIVATION; GENE MUTATION; GENE PRODUCT; INTRACTABLE EPILEPSY; KNOCKOUT MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; NOTE; SEIZURE THRESHOLD; TUBEROUS SCLEROSIS;

EID: 84864300410     PISSN: 15357597     EISSN: 15357511     Source Type: Journal    
DOI: 10.5698/1535-7511-12.1.15     Document Type: Note

References (10)

1. Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaorff CM, LaJoie J, Weiner HL, Andermann E, Franz DN, Leonard J, Connolly M, Cascino GD, Devinsky O. Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 2007;48:1625-1628.
2. Major P, Rakowski S, Simon MV, Cheng ML, Eskandar E, Baron J, Leeman BA, Frosch, MP, Thiele EA. Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia 2009;50:147-154.
3. Uhlmann EJ, Wong M, Baldwin RL, Bajenaru ML, Onda H, Kwiatkowski DJ, Yamada KA, Gutmann DH. Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 2002;52:285-296.
4. Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 2008;28:5422-5432.
5. Way SW, McKenna J 3rd, Mietzsch U, Reith RM, Wu HC, Gambello MJ. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet 2009;18:1252-1265.
6. Wu X, Sosunov AA, Tikoo R, Weiner HL, Crino PD, McKhann GM. Glutamate transport is impaired in the human tuberous sclerosis tissue. Epilepsia 2005;46(suppl 8):279.
7. Mizuguchi M, Takashima S, Yamanouchi H, Nakazato Y, Mitani H, Hino O. Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma. J Neuropath Exp Neurol 2000;59:188-196.
8. Wong M. The utility of tuber-less models of tuberous sclerosis. Epilepsia 2007;48:1629-1630.
9. Crino PB, Aronica E, Baltuch G, Nathanson KL. Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology 2010;74:1716-1723.
10. Qin W, Chan JA, Vinters HV, Mathern GW, Franz DN, Taillon BE, Bouffard P, Kwiatkowski DJ. Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol 2010;1095-1105.